Registration - In-house Corporation

ID BIOMEDICAL CORPORATION / John Picken, President

Registration Information

In-house Corporation name: ID BIOMEDICAL CORPORATION
Responsible Officer Name: John Picken, President
Initial registration start date: 2006-05-17
Registration status: Inactive
Registration Number: 780459-13189

Associated Communications

Total Number of Communication Reports: 2

Monthly communication reports in the last 6 months: 0

Version 7 of 7 (2009-06-15 to 2009-11-26)

Registration versions:

Version 7 of 7 (2009-06-15 to 2009-11-26)

Lobbying Information

Subject Matters

Government Procurement
Health
Industry
Internal Trade
Science and Technology
Taxation and Finance

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Government Procurement: we IDBC have a long-term contract with PWGSC on behalf of Health Canada concerning the supply of seasonal and pandemic influenza vaccines. This long-term contract lapses in 2011 and we are presently in active negotiations with the Can. Govt for an extension and/or renewal.
Industrial Technologies Office (ITO) used to be TPC with respect to research & development of recombinant protein vaccine & mucosal delivery mechanism of vaccine.

Communication Techniques

Written communication
Oral communication

Government Institutions

Health Canada (HC)
Industry Canada
Public Works and Government Services Canada
Treasury Board Of Canada Secretariat (TBS)

Government institutions added through a monthly communication report

Public Health Agency of Canada (PHAC)

In-house Corporation Details

Description of activities

On December 8th, 2005, GlaxoSmithKline purchased all the issued and outstanding shares of ID Biomedical Corporation. The Corporation has nonetheless survived the closing of the above noted transaction and now carries on business as IB Biomedical Corporation cob as GlaxoSmithKline Biologicals North America. The Corporation is an integrated biotechnology company dedicated to the development of innovative vaccine products. It operates in research, development, manufacturing, sales and marketing from its facilities in Canada and in the United States.

Responsible officer name and position during the period of this registration

John Picken, President

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
525 Cartier Blvd. West
Laval, QC H7V 3S8
Canada

Telephone number: 450-978-6301
Fax number: 450-978-7956

Parent Company Information

GlaxoSmithKline Inc.
- 7333 Mississauga Rd
  Mississauga, ON L5N 6L4
  Canada

Subsidiary Beneficiary Information

ID BIOMEDICAL CORPORATION does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

MICHEL BAIJOT, VP BUSINESS DEVELOPMENT | No public offices held
PAUL PINSONNAULT, SENIOR COUNSEL & SECRETARY | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

ID BIOMEDICAL CORPORATION

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
ID BIOMEDICAL CORPORATION	2009-01-16	2009-11-26

The following names have been used before July 2, 2008

ID BIOMEDICAL CORPORATION

ID BIOMEDICAL CORPORATION

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

John Picken, President (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-2 of 2

ID BIOMEDICAL CORPORATION
In-house Corporation

Designated Public Office Holders who participated in the communication:
- MARY CHAPUT, ASSOCIATE DEPUTY MINISTER | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Government Procurement, Health
Communication date: 2009-10-09
Posted date: 2009-11-24
Communication number: 13189-130554 View associated registration
ID BIOMEDICAL CORPORATION
In-house Corporation

Designated Public Office Holders who participated in the communication:
- MARY CHAPUT, ASSOCIATE DEPUTY MINISTER | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Government Procurement, Health
Communication date: 2009-10-08
Posted date: 2009-11-24
Communication number: 13189-130534 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

ID BIOMEDICAL CORPORATION / John Picken, President

Registration Information

Associated Communications

Version 7 of 7 (2009-06-15 to 2009-11-26)

Version 7 of 7 (2009-06-15 to 2009-11-26)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties